Yin Zhang, Hao Hong, Jonathan W. Engle,Yunan Yang, Todd E. Barnhart, Weibo Cai: Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging 2012;2(1):1-13. (Full text, PDF)
Selena Milicevic Sephton, Patrick Dennler, Dominique S. Leutwiler, Linjing Mu, Cindy A. Wanger-Baumann, Roger Schibli, Stefanie D. Krämer, Simon M. Ametamey: Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5. Am J Nucl Med Mol Imaging 2012;2(1):14-28. (Full text, PDF, Supplementary Data)
Dan Li, Hong Shan, Peter Conti, Zibo Li: PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging 2012;2(1):29-32. (Full text, PDF)
Ilaria Grassi , Cristina Nanni , Vincenzo Allegri, Joshua James Morigi, Gian Carlo Montini, Paolo Castellucci and Stefano Fanti: The clinical use of PET with 11C-acetate. Am J Nucl Med Mol Imaging 2012;2(1):33-47. (Full text, PDF)
Carina Mari Aparici, David Carlson, Nhan Nguyen, Randall A. Hawkins, Youngho Seo: Combined SPECT and multidetector CT for prostate cancer evaluations. Am J Nucl Med Mol Imaging 2012;2(1):48-54. (Full text, PDF)
Mian M. Alauddin: Positron emission tomography (PET) imaging with 18F-based radiotracers. Am J Nucl Med Mol Imaging 2012;2(1):55-76. (Full text, PDF)
Yasushi Ogasawara, Kuniaki Ogasawara, Taro Suzuki, Takeshi Yamashita, Hiroki Kuroda, Kohei Chida, Shunrou Fujiwara, Kenta Aso, Masakazu Kobayashi, Kenji Yoshida, Kazunori Terasaki, Akira Ogawa: Prediction of cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis using preoperative 123I-Iomazenil SPECT imaging. Am J Nucl Med Mol Imaging 2012;2(1):77-87. (Full text, PDF)
Alan DeSilva, Melinda Wuest, Monica Wang, Jeff Hummel, Karen Mossman, Frank Wuest, Mary M. Hitt: Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [18F]FDG and [18F]FLT. Am J Nucl Med Mol Imaging 2012;2(1):88-98. (Full text, PDF)
Tessa Buckle, Nynke S van den Berg, Joeri Kuil, Anton Bunschoten, Joppe Oldenburg, Alexander D Borowsky, Jelle Wesseling, Ryo Masada, Shinya Oishi, Nobutaka Fujii, Fijs WB van Leeuwen: Non-invasive longitudinal imaging of tumor progression using an 111Indium labeled CXCR4 peptide antagonist. Am J Nucl Med Mol Imaging 2012;2(1):99-109. (Full text, PDF)
Marijke De Saint-Hubert, Lieselot Brepoels, Ellen Devos, Peter Vermaelen, Tjibe De Groot, Thomas Tousseyn, Luc Mortelmans, Felix M Mottaghy: Molecular imaging of therapy response with 18F-FLT-PET following cyclophosphamide and mTOR inhibition. Am J Nucl Med Mol Imaging 2012;2(1):110-121. (Full text, PDF)
